Biomarker Evaluation and Clinical Development
Most candidate biomarkers are never adopted into clinical practice. The likelihood that a biomarker with good predictive properties will be incorporated into urologic decision-making and will improve patient care can be enhanced by following established principles of biomarker...
Saved in:
| Main Author: | Melissa Assel, Andrew Vickers |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-10-01
|
| Series: | Société Internationale d’Urologie Journal |
| Subjects: | |
| Online Access: | https://siuj.org/index.php/siuj/article/view/43/6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the Utilization of the Hospital Management Information System (SIMRS) at Madani Regional General Hospital, Palu
by: Muhammad Rifial, et al.
Published: (2025-07-01) -
Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants
by: Chenye Tang, et al.
Published: (2025-06-01) -
Externally validated and clinically useful machine learning algorithms to support patient-related decision-making in oncology: a scoping review
by: Catarina Sousa Santos, et al.
Published: (2025-02-01) -
The temporality of economic decisions applied to clinical reasoning
by: João Victor Almeida dos Santos, et al.
Published: (2024-03-01) -
Urine Biomarkers for Prostate Cancer Diagnosis and Progression
by: Jeremy Clark, Rachel Hurst, Mark Simon Winterbone, Hardev Pandha, Antoinette Perry, Sophie McGrath, Richard Morgan, Adele E Connor, Asia C Jordan, Deirdre Winrow, Colin Cooper
Published: (2021-05-01)